New York, USA – September 2, 2022 – Studies showed that many coronaviruses, such as SARS-CoV, avian influenza, human immunodeficiency virus infection(HIV), and acquired immune deficiency syndrome (AIDS), have caused fatalities among humans during the past two decades. These viruses have dealt a catastrophic blow to people’s lives, economic development, and social stability, meanwhile presenting unprecedented risks to public health and safety. Thereby, it is essential to investigate and develop new viral antibodies to address the growing research needs.
With extensive experience in antibody development, Creative Biolabs offers a range of virus antibodies to promote researchers’ virology studies, including but not limited to secondary antibodies and pseudoviruses. In addition to antibodies, ViroAntibody discovery, engineering, and customization services are also available to help achieve diversified client research goals.
Compared to primary antibodies, secondary antibodies sometimes require an extra purification process in order to enhance specificity and/or minimize non-specificity, which generally consists of a detectable tag or label facilitating detection or purification. Besides, due to their ability to conjugate many labels, the choice of secondary antibodies ultimately depends on downstream applications. Typical applications include western blot, ELISA, and flow cytometry (FC).
Creative Biolabs provides secondary antibody options of different purity levels, specificities, and label types for fluorescent and those with different conjugates to support the flexibility of experimental design for researchers. In addition, scientists can advise clients on selecting the most appropriate secondary antibody for their unique applications and studies.
Due to the lack of virulent components, pseudoviruses practically eliminate the possibility of causing an active infection in an exposed individual. More importantly, the pseudovirus system is quantifiable and can be rapidly produced, supporting researchers during the detection of antibodies.
Creative Biolabs offers pseudoviruses generated by co-transfection of 293T cells with a packaging vector, a reporter vector, and a plasmid encoding specific viral proteins. According to the different research demands for SARS-CoV-2, Creative Biolabs has offered various options for clients to freely choose from:
* Lenti-SARS-CoV-2 S Pseudovirus [Luciferase]
* Lenti-SARS-CoV-2 S Pseudovirus [GFP]
* Retro-SARS-CoV-2 ORF1 a/b & E & N Pseudovirus
To learn more about other virus antibodies at Creative Biolabs, please visit https://viroantibody.creative-biolabs.com.
About Creative Biolabs
As a leading service provider in various antibody production and engineering, Creative Biolabs offers high-quality and ready-to-use catalog antibodies as well as flexible and comprehensive customized services for antibody production.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://viroantibody.creative-biolabs.com
